Patients With Atypical Femur Fractures Have the Same Mortality as the Background Population--Drug-Channeling Bias, Bisphosphonate Effects, and Public Health Implications

J Bone Miner Res. 2016 Mar;31(3):488-90. doi: 10.1002/jbmr.2801. Epub 2016 Feb 28.
No abstract available

Publication types

  • Comment

MeSH terms

  • Bias
  • Bone Density Conservation Agents / therapeutic use
  • Diphosphonates / therapeutic use*
  • Femoral Fractures / drug therapy
  • Humans
  • Public Health*

Substances

  • Bone Density Conservation Agents
  • Diphosphonates